• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类免疫缺陷病毒相关面部脂肪萎缩——当前治疗方案综述

HIV-associated facial lipoatrophy--review of current therapy options.

作者信息

Bechara Falk Georges, Sand M, Potthoff A, Altmeyer P, Brockmeyer N H

机构信息

Department of Dermatology and Allergology, Ruhr-University Bochum, St. Josef Hospital, Gudrunstr. 56, 44791 Bochum, Germany.

出版信息

Eur J Med Res. 2008 Mar 31;13(3):93-9.

PMID:18499554
Abstract

Highly active antiretroviral therapy (HAART) has dramatically improved the life expectancy for HIV-infected patients. Long-term complications of both HIV-infection and antiretroviral agents are therefore of increasing concern. Facial lipoatrophy (FLA) is a stigmatizing complication associated with sever social impact and a reduced quality of life for the patient. - We aimed to review the treatment options of HIV-associated FLA. The current treatments available for treating FLA are limited and can be classified in three main categories: I. Medial therapy, II. Injectables with different duration of effect, and III. Surgical treatment options. Medical therapy can provide a small benefit but improvement is, at best, slow and partial. Injectables can yield marked results but are costly, time consuming and may be associated with complications such as granuloma formation. Surgical options such as augmentation with specially designed silicone implants may be of benefit for severe cases of FLA, however, they are associated with higher surgical complications and do not account for the dynamic process of FLA. - To summarize, until today no ideal strategies for treatment of HIV-associated FLA are available, and new therapies are strongly required. heart disease.

摘要

高效抗逆转录病毒疗法(HAART)显著提高了HIV感染患者的预期寿命。因此,HIV感染和抗逆转录病毒药物的长期并发症日益受到关注。面部脂肪萎缩(FLA)是一种具有污名化的并发症,会对患者造成严重的社会影响并降低其生活质量。——我们旨在综述HIV相关FLA的治疗选择。目前可用于治疗FLA的方法有限,主要可分为三大类:一、药物治疗;二、效果持续时间不同的注射剂;三、手术治疗选择。药物治疗能带来些许益处,但改善程度充其量缓慢且有限。注射剂可产生显著效果,但成本高昂、耗时,且可能伴有诸如肉芽肿形成等并发症。诸如使用特制硅胶植入物进行填充等手术选择,对于严重的FLA病例可能有益,然而,它们会带来更高的手术并发症风险,且无法应对FLA的动态变化过程。——总之,直至今日,尚无理想的治疗HIV相关FLA的策略,强烈需要新的治疗方法。心脏病。

相似文献

1
HIV-associated facial lipoatrophy--review of current therapy options.人类免疫缺陷病毒相关面部脂肪萎缩——当前治疗方案综述
Eur J Med Res. 2008 Mar 31;13(3):93-9.
2
Long-term complications of antiretroviral therapy: lipoatrophy.抗逆转录病毒疗法的长期并发症:脂肪萎缩。
Int J Clin Pract. 2007 Jun;61(6):999-1014. doi: 10.1111/j.1742-1241.2007.01385.x.
3
Management options for facial lipoatrophy.面部脂肪萎缩的治疗选择。
AIDS Read. 2004 Dec;14(12):639-40, 645-50.
4
[Facial lipodystrophy in patients with HIV infections troublesome to treat].[人类免疫缺陷病毒感染患者的面部脂肪代谢障碍难以治疗]
Lakartidningen. 2002 Sep 26;99(39):3826-9.
5
Restorative interventions for HIV facial lipoatrophy.HIV面部脂肪萎缩的恢复性干预措施。
AIDS Rev. 2008 Apr-Jun;10(2):116-24.
6
A ribose-crosslinked collagen filler treatment for facial lipoatrophy associated with the treatment of human immunodeficiency virus.一种用于治疗与人类免疫缺陷病毒治疗相关的面部脂肪萎缩的核糖交联胶原蛋白填充剂治疗方法。
J Drugs Dermatol. 2008 Dec;7(12):1169-71.
7
Long-term effect of polyalkylimide gel injections on severity of facial lipoatrophy and quality of life of HIV-positive patients.聚烷基酰亚胺凝胶注射对HIV阳性患者面部脂肪萎缩严重程度和生活质量的长期影响。
Aesthetic Plast Surg. 2008 Nov;32(6):873-8. doi: 10.1007/s00266-008-9189-8. Epub 2008 Jun 13.
8
Porcine filler for facial lipoatrophy associated with human immunodeficiency virus treatment.用于与人类免疫缺陷病毒治疗相关的面部脂肪萎缩的猪源填充物。
J Drugs Dermatol. 2008 Sep;7(9):884-6.
9
Persistence of lipoatrophy after a four-year long interruption of antiretroviral therapy for HIV1 infection: case report.HIV-1感染抗逆转录病毒治疗中断四年后脂肪萎缩持续存在:病例报告
BMC Infect Dis. 2005 Oct 3;5:80. doi: 10.1186/1471-2334-5-80.
10
[Metabolic abnormalities, lipodystrophy and cardiovascular risk in HIV-infected patients].[HIV 感染患者的代谢异常、脂肪营养不良与心血管风险]
Rev Prat. 2006 May 15;56(9):987-94.